Reviving exhausted T cells to tackle immunotherapy-resistant cancers

One of the biggest goals of immunotherapy is to reverse T cell exhaustion to boost the immune system’s ability to destroy cancerous cells. Researchers at Sanford Burnham Prebys studying melanoma have found a new way to make this happen.

Taking a 3D view of the genome may help treat pediatric brain cancers

Sanford Burnham Prebys researchers have a new way of looking at childhood brain tumors—and it’s revealing new avenues to treat them.

Charles Spruck awarded $1.7M to advance “ancient virus” treatment for prostate cancer

With the help of a new grant from the U.S. Department of Defense for more than $1.7 million, Associate Professor Charles Spruck, Ph.D., will advance an innovative therapeutic approach for metastatic prostate cancer.

Do worms get stressed? We asked an expert

April is National Stress Awareness Month, so we talked to Assistant Professor Caroline Kumsta about how she uses worms to study the cellular stress responses that occur with aging.

How cancer research silos perpetuate inequity in cancer outcomes: An interview with Svasti Haricharan

To honor National Minority Health Month, we spoke to Svasti Haricharan about her work, who recently published a paper describing some of the shortfalls of the current research focusing on cancer disparities.